RE: Jamrock18 Jul 2025 07:00
Hot chip
No it’s not a case of just labelling existing tests. MHC has registered phlebotomy tones phlebotomy tests recently. We haven’t had any details of what these tests are which makes it more exciting.
MHC has clearly realised Boots will push tests in their own label first. Then there’s pharmacy first which could play a roll in bringing down NHS waiting lists. If any of these tests make it onto to pharmacy first then NHS patients can have the tests paid for by the NHS. It’s clear that the government is rolling out care in the community and there no Better pharmacy other than Boots which is making it’s services and products available to patients..
Between MHC, Boots and others like ABDX the government plans to utilise these facilities to transform patients experience, save money in GP appointments and waiting times.
The landscape is moving from sitting in a waiting room in GPs waiting area to the convenience of places like Boots.
MHC has invested millions in Digital Data and compliance regulation so they clearly share the vision of the government changes coming.
Boots will probably do an advertising campaign soon I guess. Hopefully TV to get the message across they are ready for the public both private and NHS patients.
ABDX labels iron and vitamin D tests for Boots and upon this announcement last year there share rocketed way more than we have.
Also remember MHC hasn’t diluted share holders value.
It’s impossible to give numbers because I believe government changes could be huge and until they start next month Boots and MHC don’t really know how the service will go down. One thing is sure 💯. The NHS and patients experience will be changing for the good whilst waiting lists falling.
Sign In
Follow the stocks
